Test description
Testing for high and moderately high risk genes in patients with a personal and family history of breast and ovarian cancer.
Test information
Test name
BRAoVO™ Breast/Ovarian Gene panel
Clinical indication
Used to determine presence of pathogenic variations in patients with a personal and/or family history suggestive of high risk (>10%) of having Hereditary Breast and Ovarian Cancer Syndrome.
Gene(s)
ATM, BARD1, BRCA1, BRCA2, BRIP1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, TP53, MLH1, MSH2, MSH6, PMS2, EPCAM
Method
Massively Parallel Sequencing
Turn around time
4 - 5 weeks
Price
$499 when not Medicare eligible
Test request form
Cancer Genetics request form preferred. Standard pathology request form accepted.
Sample type
Blood x 2
Collection type
EDTA
Special instructions
2 x Bloods taken at 10 minute intervals. Pre-test genetic counselling required. Patient to provide consent prior to testing.
FAQ
No items found.
Resources
No items found.